MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-12-2026
AVITA Medical Total Liabilities 2011-2026 | RCEL
Annual Total Liabilities AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 73 M | 75 M | 61.9 M | 13 M | 11.4 M | 10.1 M | 4.87 M | 2.95 M | 1.96 M | 1.31 M | 941 K | 1.68 M | 2.24 M | 2.2 M | 1.54 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 75 M | 941 K | 17.6 M |
Quarterly Total Liabilities AVITA Medical
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70.4 M | 74.1 M | 75 M | 68.6 M | 63.5 M | 64 M | 61.9 M | 17.4 M | 16.5 M | 14.3 M | 13 M | 11.7 M | 9.95 M | 8.68 M | 11.4 M | 9.68 M | 9.85 M | 9.85 M | 9.71 M | 9.93 M | 10.1 M | 10.1 M | - | - | 4.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 75 M | 4.95 M | 28.4 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Delcath Systems
DCTH
|
12.4 M | $ 9.2 | 2.45 % | $ 330 M |  USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
24 M | - | -0.97 % | $ 54.4 M | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
5.34 M | $ 2.16 | 7.46 % | $ 1.31 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 9.55 | 0.1 % | $ 735 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Inogen
INGN
|
106 M | $ 6.42 | 1.58 % | $ 171 M | USA |
 |
IRIDEX Corporation
IRIX
|
24.9 M | $ 1.33 | -1.85 % | $ 21.5 M | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
IRadimed Corporation
IRMD
|
14.2 M | $ 101.78 | 0.8 % | $ 1.29 B | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
LivaNova PLC
LIVN
|
1.41 B | $ 63.3 | 1.44 % | $ 3.45 B |  Britain |
 |
LENSAR
LNSR
|
47.7 M | $ 5.58 | 0.36 % | $ 64.3 M | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 37.08 | 1.42 % | $ 1.15 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Medtronic PLC
MDT
|
43.4 B | $ 87.89 | 1.51 % | $ 113 B | USA |
 |
NanoVibronix
NAOV
|
3 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 24.66 | -0.16 % | $ 208 M | USA |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
MiMedx Group
MDXG
|
86.1 M | $ 4.1 | -0.73 % | $ 606 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
36.3 M | - | - | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
2.24 M | $ 2.32 | 7.41 % | $ 3.62 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Orthofix Medical
OFIX
|
401 M | $ 11.93 | 1.79 % | $ 472 M |  Curacao |
 |
InspireMD
NSPR
|
14.2 M | $ 1.77 | -1.12 % | $ 114 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 11.39 | -0.78 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
399 M | $ 336.27 | 0.63 % | $ 13.1 B | USA |
 |
Myomo
MYO
|
27.2 M | $ 0.7 | -0.1 % | $ 29.3 M | USA |
 |
Insulet Corporation
PODD
|
1.68 B | $ 216.0 | -4.21 % | $ 15.2 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
20.9 M | $ 2.29 | -4.58 % | $ 134 M | Israel |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 3.71 | -5.12 % | $ 138 M |  France |
 |
Profound Medical Corp.
PROF
|
12.7 M | $ 5.82 | 13.01 % | $ 180 M | Canada |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 16.23 | 2.01 % | $ 381 M | USA |
 |
Quanterix Corporation
QTRX
|
123 M | $ 3.96 | 3.66 % | $ 169 M | USA |